PE vs GMR [R for BE/BA]

posted by roman_max – Russia, 2018-12-13 23:11 (857 d 11:29 ago) – Posting: # 19690
Views: 6,219

Hi ElMaestro,
Thanks for the opinion. Indeed, no problem when there are no dropouts from the study. And definitely you don't know how a particular software use its sophisticated logic in calculations, applying coefficients, modeling etc. Sometimes I also use SPSS and it's syntax, but it cannot account for disbalance like R lm function. So it depends..
So, as a solution I will make a footnotes to tables to explain "readers" in RA what a particular metrics mean and how they were calculated / estimated. Along with SAP :)
Hope it will be sufficient to our regulator not to be knocked down :-)

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 10 (0 registered, 10 guests [including 3 identified bots]).
Forum time: Monday 11:40 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5